Celgene is a pharmaceutical company with a major focus on the discovery, development and commercialization of small molecules for cancer and immunological diseases.Celgene's medical research and development team is working to extend the boundaries in the areas of small molecule immunotherapeutic and biocatalytic chiral chemistry by developing both new pharmaceuticals and chirally pure versions of existing drugs. Celgene's agrochemical unit, Celgro, is dedicated to the development of chirally pure crop protection agents.
Our goal is to provide hope and ease suffering through the discovery and development of products for therapies for patients with severe and difficult to treat diseases.
| Contact Details: |
| 86 Morris Avenue |
| Summit |
| NJ |
| 07901 |
| United States of America |
| Tel: | 1-908-673-9000 |
| Fax: | 908 271 4184 |
| Email: | |
| WWW: | www.celgene.com/
|
|
Loading...
|
Recent Publications by Celgene Corporation: |  |
CC-4047 promotes Th1 cell differentiation and reprograms polarized human Th2 cells by enhancing transcription factor T-bet.
The IMiDs(R) immunomodulatory drugs are an expanding family of compounds... | 21st June, 2008
| Celgene Corporation, 4550 Towne Centre Court, San Diego, CA 92121, USA.
| Clin Immunol. 2008 Jun 17;.
DOI Direct Link |
UTILITY OF THE OATP1B2 KNOCKOUT MOUSE MODEL FOR EVALUATING THE ROLE OF OATP1B2 IN THE HEPATIC UPTAKE OF MODEL COMPOUNDS.
We generated the organic anion transporting polypepetide (Oatp) 1b2... | 17th June, 2008
| Celgene Corporation.
| Drug Metab Dispos. 2008 Jun 12;.
DOI Direct Link |
Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanoma.
Uveal melanoma is associated with a high mortality rate once metastases... | 12th June, 2008
| Centre Pluridisciplinaire d'Oncologie, Centre Hospitalier Universitaire
| Int J Cancer. 2008 Sep 1;123(5):1215-8.
DOI Direct Link |
Simultaneous determination of cations, zwitterions and neutral compounds using mixed-mode reversed-phase and cation-exchange high-performance liquid chromatography.
A novel mixed-mode reversed-phase and cation-exchange high-performance... | 31st May, 2008
| Analytical Research and Development, Celgene Corporation, Summit, NJ
| J Chromatogr A. 2008 Mar 28;1185(2):185-93. Epub 2008 Feb 12.
DOI Direct Link |
An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain.
Revlimid((R)) (Lenalidomide, CC-5013) and CC-4047 are IMiDs((R))... | 9th May, 2008
| Multidisciplinary Oncology Center, University of Lausanne Hospitals
| Cancer Immun. 2008 Mar 27;8:6.
|
→View more Celgene Corporation research publications. |
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 20 individuals from Celgene Corporation using this service.
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 1034 times since April 2007, the link to the organisation's website has been followed 120 times
Recent Search Terms used to find this page: IMiDs patent | celgene pharma | celgene pharma | VAT number celgene corporation | celgene email exchange | VAT number celgene corporation | UK Managing Director of Celgene | celgene UK managing director | t | t | .
Search for more companies in Summit
Search for more companies in NJ
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Celgene Corporation
